Jaguar Health (JAGX) Other Non Operating Income (2015 - 2026)
Jaguar Health's (JAGX) quarterly Other Non Operating Income came in at $205000.0 in Q1 2026, up 83.04% year-on-year from $112000.0 in Q1 2025, and up 169.02% on a QoQ basis from -$297000.0 in Q4 2025.
Jaguar Health (JAGX) Other Non Operating Income (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Other Non Operating Income data on file, last reported at $205000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 83.04% year-over-year to $205000.0 in Q1 2026; TTM through Mar 2026 was $136000.0, a 291.55% increase from a year earlier, with the FY2025 full-year figure at $43000.0, down 15.69% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $205000.0, up from -$297000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for JAGX reached as high as $832000.0 in Q1 2022 and fell as low as -$1.1 million in Q2 2022.
- Historically, Other Non Operating Income has averaged $5562.5 across 5 years, with a median of $69000.0 in 2023.
- Across the five-year window, Other Non Operating Income slumped 6276.47% in 2022 and soared 2050.0% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at -$158000.0 in 2022, then soared by 262.03% to $256000.0 in 2023, then jumped by 47.66% to $378000.0 in 2024, then plunged by 178.57% to -$297000.0 in 2025, then surged by 169.02% to $205000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $205000.0 in Q1 2026, -$297000.0 in Q4 2025, and -$94000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.37 Bn | 468.58 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.58 Bn | 116.33 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.54 Bn | 62.78 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.17 Bn | 62.17 Bn | - |
| 7 | Argenx Se | 54.63 Bn | 49.44 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.11 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.17 Bn | 36.17 Bn | - |
| 10 | Jaguar Health | 523,524.81 | -9.54 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 205,000.00 |
| Dec 31, 2025 | -297,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Jun 30, 2025 | 322,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Dec 31, 2024 | 378,000.00 |
| Sep 30, 2024 | 168,000.00 |
| Jun 30, 2024 | -729,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 256,000.00 |
| Sep 30, 2023 | -70,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | -12,000.00 |
| Sep 30, 2022 | -158,000.00 |
| Jun 30, 2022 | -1.08 Mn |
| Mar 31, 2022 | 832,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -17,000.00 |
| Mar 31, 2021 | -753,000.00 |
| Dec 31, 2020 | -1.30 Mn |